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Abstract The calcium-activated potassium ion channel
gene (KCNN3) is located in the vicinity of the familial
hemiplegic migraine type 2 locus on chromosome 1q21.3.
This gene is expressed in the central nervous system and
plays a role in neural excitability. Previous association
studies have provided some, although not conclusive, evi-
dence for involvement of this gene in migraine suscepti-
bility. To elucidate KCNN3 involvement in migraine, we
performed gene-wide SNP genotyping in a high-risk
genetic isolate from Norfolk Island, a population des-
cended from a small number of eighteenth century Isle of
Man ‘Bounty Mutineer’ and Tahitian founders. Phenotype
information was available for 377 individuals who are
related through the single, well-defined Norfolk pedigree
(96 were affected: 64 MA, 32 MO). A total of 85 SNPs
spanning the KCNN3 gene were genotyped in a sub-sample
of 285 related individuals (76 affected), all core members
of the extensive Norfolk Island ‘Bounty Mutineer’ gene-
alogy. All genotyping was performed using the Illumina
BeadArray platform. The analysis was performed using the
statistical program SOLAR v4.0.6 assuming an additive
model of allelic effect adjusted for the effects of age and
sex. Haplotype analysis was undertaken using the program
HAPLOVIEW v4.0. A total of four intronic SNPs in the
KCNN3 gene displayed significant association (P \ 0.05)
with migraine. Two SNPs, rs73532286 and rs6426929,
separated by approximately 0.1 kb, displayed complete LD
(r2 = 1.00, D0 = 1.00, D0 95% CI = 0.96–1.00). In all
cases, the minor allele led to a decrease in migraine risk
(beta coefficient = 0.286–0.315), suggesting that common
gene variants confer an increased risk of migraine in the
Norfolk pedigree. This effect may be explained by founder
effect in this genetic isolate. This study provides evidence
for association of variants in the KCNN3 ion channel gene
with migraine susceptibility in the Norfolk genetic isolate
with the rarer allelic variants conferring a possible pro-
tective role. This the first comprehensive analysis of this
potential candidate gene in migraine and also the first study
that has utilised the unique Norfolk Island large pedigree
isolate to implicate a specific migraine gene. Studies of
additional variants in KCNN3 in the Norfolk pedigree are
now required (e.g. polyglutamine variants) and further
analyses in other population data sets are required to clarify
the association of the KCNN3 gene and migraine risk in the
general outbred population.
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Introduction
Migraine is a chronic and debilitating neurovascular dis-
ease characterised by recurrent attacks of severe headache
that is usually accompanied by nausea, vomiting, photo-
phobia and phonophobia. Clinical diagnosis is established
by fulfilment of symptom-based criteria defined by the
International Headache Society (IHS), which recognises
two primary sub-types: migraine with aura (MA) and
migraine without aura (MO) [1]. Migraine is highly pre-
valent in Western nations, afflicting some 12% of the adult
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population (males 5.6%, females 17.1%) [2]. The disorder
has a strong genetic component, with population-based
studies reporting heritability to vary from 0.34 to 0.57 [3].
However, heritability estimates as high as 0.96 for MA and
0.77 for MO have been reported in a Dutch population
isolate [4]. Genetic liability is further supported by con-
cordance rates in twins [5] and familial aggregation [6].
Non-genetic (environmental) factors are also thought to
influence predisposition, with ethnic, geographic, lifestyle
and socioeconomic factors shown to be associated with
variable risk of migraine [7].
The molecular genetics of familial hemiplegic migraine
(FHM), a rare mendelian variant of migraine may provide
insight into the pathophysiology of more common forms
of migraine. FHM is distinguished from general migraine
by the presence of transient motor weakness accompany-
ing typical aura symptoms. Mutations in the neuronal
voltage-gated (P/Q-type) Ca2? channel gene (CACNA1A;
MIM601011) [8], the Na?/K? ATPase gene (ATP1A2; MIM
182340) [9] and the neuronal voltage-gated Na? channel
gene (SCN1A; MIM182389) [10] have been identified in
regions on chromosomes 19p13, 1q21-23 and 2q24,
respectively. CACNA1A mutations produce gain-of-function
of the CaV2.1 channel and result in increased neurotrans-
mitter release from cortical neurons [11]. Mutations in
ATP1A2 produce loss-of-function of the a2 Na?, K?-ATP-
ase, whereas mutations in SCN1A accelerate recovery from
fast inactivation of sodium-voltage channels [11]. The
functional consequences of mutations in these genes support
the involvement of ion and neurotransmitter disturbances in
migraine pathophysiology [12–14]. The calcium-activated
potassium channel gene (KCNN3; MIM602983) is in the
vicinity of the FHM2 linked region on chromosome 1q21-23
region and proximal to a region linked to both FHM and
typical migraine on chromosome 1q31 [15].
Calcium-activated potassium channels contribute to the
after-hyperpolarisation in central neurons [16]. Small-
conductance calcium-activated potassium channels such as
KCNN3 play a crucial role in determining neuronal firing
rates via the after-hyperpolarisation that occurs during an
action potential. KCNN3 is widely expressed in the brain, is
potassium selective, voltage independent, and has high
sensitivity to increases in intracellular calcium levels that
typically occur during an action potential [16, 17]. Varia-
tions in this gene may facilitate initiation of CSD and tri-
geminal sensitivity, thus making it a functionally plausible
migraine candidate susceptibility gene.
Previous case–control association studies have investi-
gated CAG repeats in exon 1 in Australian and German
case–control migraine cohorts [18, 19]. Results from the
Australian cohort (202 case; 221 controls) displayed a
trend for migraineurs to have increased CAG repeat length
compared to controls. The Mossner study (190 cases, 232
controls) also found evidence of an association with alleles
of the second polyglutamine repeat in migraineurs [19].
These results suggest potential involvement of KCNN3 in
migraine susceptibility.
The present study sought to perform gene-wide SNP
genotyping of the migraine candidate gene, KCCN3, in a
unique multigenerational pedigree from the Norfolk
‘Mutiny on the Bounty’ population isolate. These indi-
viduals are the living descendents of nine Isle of Man,
‘Bounty’ Mutineers and six Tahitian women, who colon-
ised the uninhabited Pitcairn Island in 1790 after the
infamous Mutiny aboard the HMAS Bounty. This initial
Pitcairn Island colony experienced population bottlenecks
and was characterised by minimal migration and consan-
guinity. The small community expanded in severe geo-
graphic and genetic isolation until 1856, when they were
relocated to the then uninhabited Norfolk Island, located
almost 1,500 km west of Brisbane, Australia in the South
Pacific Ocean. The Norfolk pedigree is a novel resource
to evaluate KCNN3 gene involvement in migraine
susceptibility.
Methods
Subjects
The study was approved by the Griffith University Human
Research Ethics Committee prior to commencement. Prior
to participation signed, informed consent was obtained
from all participants. Data collection procedures have been
described in detail elsewhere [20]. Phenotypic data and
biological specimens (venous blood) were obtained from
600 subjects (261 males, 339 females) with a mean age of
50.8 years (standard deviation of 16.4 years). DNA was
isolated using a standard salting-out procedure [21]. Phe-
notypic data were obtained via a comprehensive medical
questionnaire that surveyed migraine family history,
symptoms, triggers, and medication use. Migraine was
diagnosed in accordance with current IHS guidelines by
interviews using a validated migraine questionnaire and
followed up by qualified migraine diagnosticians [1]. In
total, 600 subjects participated in the study, of whom 154
(25.7%) were positive for migraine (MA and/or MO) of the
total cohort. The rate of migraine in the Norfolk population
is substantially higher than the estimated 12% affection
rate in general, out-bred, Caucasian populations [2]. This
finding reflects the unique population sub-structure, a
highly complex, 11-generation pedigree originating from a
limited number of founding individuals. At the time of the
study, approximately 80% of permanent residents on the
island were of ‘Bounty’ mutineer lineage [22]. This pop-
ulation is characterised by founder effect, geographical and
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cultural isolation, high levels of consanguineous unions
during early population expansion, population bottlenecks,
admixture and homogenous environment [20]. These fac-
tors may impact significantly on the frequency of particular
traits or diseases as well as genetic drift within a popula-
tion, as demonstrated by the high levels of founder muta-
tions in the Dutch population [23].
Genealogical data were obtained from multiple sources,
including questionnaire, municipal and historical records.
Historically, Pitcairn Island was settled by 9 Isle of man
‘Bounty’ mutineers, 12 Tahitian women and 6 Tahitian
men in 1790. Pedigree reconstruction and validation indi-
cate that the present population are the descendents of the
original 9 Isle of Man ‘Bounty mutineers’ founders, 6
Tahitian female founders and 2 additional Caucasian sail-
ors who joined the small colony during the early nineteenth
century [24]. Including recent married-in individuals, a
total of 377 participants are related through the Norfolk
Island ‘Mutiny on the Bounty’ pedigree. In total, 96
(25.5%) of the 377 pedigree members were migraine
positive. To facilitate analysis, the original pedigree
(N = 6,537) was split (N = 1,078) using a peeling algo-
rithm in the pedigree database management system, PED-
SYS (Southwest Foundation for Biomedical Research, San
Antonio, TX, USA) [25]. This 1,078-member pedigree has
been previously employed in genome-wide screens of
cardiovascular risk traits [26].
Genotyping
Genotyping was performed in a sub-sample of 285 related
individuals (135 males, 150 females) selected from the core
377-member pedigree. These individuals possessed high
inheritance information and were extremely informative
for pedigree-based analysis, facilitating cost-effective
genotyping. Of these related individuals, 76 are migraine
positive (22 males, 54 females). DNA samples were gen-
otyped according to the manufacturer’s instructions on an
Illumina Infinium DNA analysis BeadChip requiring
200 ng of DNA per sample. A total of 85 SNPs were
genotyped across the KCNN3 gene. Samples were scanned
on the Illumina BeadArray 500GX Reader. Raw data were
obtained using Illumina BeadScan image data acquisition
software (version 2.3.0.13) and analysed using Illumina
BeadStudio software (version 1.5.0.34). Individuals with a
call rate below 95% and SNPs with a call rate below 99%,
deviating from Hardy–Weinberg equilibrium or with a
minor allele frequency of less than 1% were excluded from
the analysis. The Pedigree RElationship Statistical Test
(PREST) was used to verify the pedigree structure and
detect relationship misspecification. Genotypic data were
analysed for discrepancies using the PEDSYS program
INFER and Simwalk2. Discrepant genotypes were blanked
prior to analysis.
Statistical analysis
All statistical analyses on related individuals were con-
ducted using variance component-based methodology
implemented in the Sequential Oligonucleotide Link-
age Analysis Routines (SOLAR) version 4.0.6 software
package (Southwest Foundation for Biomedical Research,
San Antonio, TX, USA) [27]. Gene-wide association
testing was performed using measured genotype analysis,
embedded in a variance component-based linkage model
[28]. The analysis performed assumed an additive model of
allelic effect, where SNP genotypes AA, AB and BB were
coded as -1, 0 and 1, respectively, and used as a linear
predictor of the phenotype. The analysis was adjusted for
the covariate effects of age, age-squared, sex and their
interactions to allow for differential symptom prevalence in
males and females and adjust for variable age of onset. A
total of 85 SNPs across the KCCN3 gene were available for
the analysis. The local type I error, a = 5.8 9 10-4 was
calculated by Bonferroni adjustment. SNP results were
annotated using the Whole Genome Association Study
Viewer (WGAViewer) program (http://people.genome.
duke.edu/*dg48/WGAViewer/) and NCBI Build 37.1
[29]. Linkage disequilibrium was assessed using the pro-
gram Haploview [30]. Due to the presence of a breeding
loop in the trimmed pedigree file, the pedigree was further
split to facilitate Haploview analysis within a pedigree
framework, using the partitioning program Jenti [31].
Results
This study undertook pedigree-based association testing to
determine involvement of the KCNN3 gene in suscepti-
bility to familial migraine in a unique isolated population
from Norfolk Island. Of the 85 SNPs within the KCNN3
gene on chromosome 1, four displayed nominal level
association with migraine. Two of the top four SNPs were
determined to be in complete LD (r2 = 1.0, D0 = 1.00,
D0 95% CI = 0.96–1.00). Beta coefficients and corre-
sponding P values for the four significant SNPs are detailed
in Table 1. The probit regression beta coefficient is a
measure of risk. A negative beta indicates that the minor
allele increases migraine risk, a positive beta indicates a
decreased risk. The minor allele for the four significant
SNPS conferred a decreased risk of migraine in the Norfolk
pedigree. This suggests that the common gene variants in
KCNN3 may confer an increased risk of migraine in the
Norfolk pedigree.
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The Norfolk population isolate is unique due to the
presence of population admixture during the founding
event. The degree of Polynesian and Caucasian admixture
in the Norfolk pedigree has been previously estimated
using the ancestry coefficient (Q) [24]. Polynesian and
Caucasian ancestries were estimated as 12 and 88%,
respectively. Due to this unique population structure we
compared the minor allele frequencies of our top four
SNPS with those reported in Phase III data from the
Human HapMap populations (http://hapmap.ncbi.nlm.nih.
gov/). Results are detailed in Table 2. Allelic frequencies
in the Norfolk pedigree are similar to the CEU population.
Discussion
KCNN3 is widely expressed throughout the brain and CNS,
but is predominant in the hypothalamus, particularly in
neurosecretory neurons (gonadotropin releasing hormone,
dopamine and vasopressin neurons) [32]. There is also an
evidence to suggest that oestrogen levels may influence
KCNN3 expression and possibly neuronal excitability [32].
Considering the role of KCCN3 in neural firing via ion
transport, as well as its relation to dopaminergic and
oestrogen pathways, it can be considered a potential
modifying gene in migraine susceptibility. The influence of
circulating oestrogen levels on KNCC3 expression may
explain the sex-specific variation in migraine incidence and
prevalence observed across age categories [33]. Risk
variants and haplotypes in dopamine metabolism genes,
DBH [34], DDC [35], MAOA [35], and SLC6A3 [36], are
reported to influence migraine risk, as are variants in the
oestrogen receptor gene, ESR1 [37, 38]. Whilst conflicting
results are reported in different populations [39, 40],
overall evidence suggests that genes involved in neuro-
transmitter pathways, particularly ion channel function and
transport, are good migraine candidates.
Association between KCNN3 polyglutamine repeat
expansion length and migraine susceptibility has been
demonstrated in two independent studies [18, 19]. To
determine whether variants in the KCNN3 gene are asso-
ciated with migraine risk, we utilised a small genetic iso-
late from Norfolk Island and performed a comprehensive
85 SNP analysis of this gene. The multigenerational
‘Mutiny on the Bounty’ pedigree is a unique resource for
genetic studies. Pedigree characteristics include 17 found-
ing individuals, admixture, as well as cultural and geo-
graphical isolation. At the time of recruitment, the Island’s
population of permanent residents under the Norfolk Island
Immigration Act 1980 totalled 1,574 individuals [22].
Migraine was not analysed as a single phenotype as our
hypothesis was that a common gene(s) basis is involved in
migraine generally in accordance with Nyholt et al. [41].
Furthermore, a small sample size made subgroup analysis
statistically impractical. A migraine prevalence (MA and/
or MO) of 25.7% was observed in a population sample of
600 individuals. The most significantly associated SNPs
(P \ 0.005) in this pedigree were rs4845663, rs7532286,
rs6426929 and rs1218551, with the minor allele in each
case conferring protection against migraine risk.
A recent study of ion transport genes and migraine sus-
ceptibility provided evidence for a potential role of the
potassium, voltage-gated, ion channel, KCNE2 gene on
chromosome 21q22.11 [42]. Of particular relevance to our
current study were results of KCCN3 gene screening in the
Finnish case–control cohort [42]. Multiple SNPs within the
KCCN3 gene and in the vicinity of the markers included in
this study produced nominal level allelic association with
migraine. Similar to findings in the Norfolk pedigree, a
protective role was implicated for a KCCN3 allelic variant
and MA susceptibility (rs11810841; P = 0.0081; OR =
0.8232). Although different SNPs were implicated by
Nyholt et al. [42] in KCNN3, when these results are con-
sidered with the findings of Curtain et al. [18] and Mo¨ssner
et al. [19], they add substantial weight to our new findings in
Norfolk Islanders. Overall results in the Norfolk pedigree,
and Finnish, German and Australian populations suggest
that common variants of small effect size in the KCCN3
Table 1 Summary of KCCN3 SNPS displaying gene-wide
significance
dbSNP rs
no.
NCBI build 37.1 position
(bp)
Function Beta P value
rs4845663 154692088 Intronic 0.286 0.023
rs7532286a 154750816 Intronic 0.283 0.024
rs6426929a 154750989 Intronic 0.283 0.024
rs1218551 154801173 Intronic 0.315 0.038
a SNPs displaying complete LD (r2 = 1.0, D0 = 1.00, D0 95%
CI = 0.96–1.00)
Table 2 SNP minor allele frequencies in Norfolk Islanders compared
to other populations
dbSNP rs
no.
Minor/major
allele
Minor allele frequency (MAF)
NI CEU
(C)
CHB
(H)
JPT
(J)
YRI
(Y)
rs4845663 C/T 0.478 0.411 0.331 0.217 0.935
rs7532286 A/C 0.371 0.420 0.281 0.323 0.701
rs6426929 A/G 0.371 0.420 0.283 0.323 0.476
rs1218551 G/A 0.265 0.341 0.036 0.084 0.153
CEU (C) Utah residents with Northern and Western European
ancestry from the CEPH collection, CHB (H) Han Chinese in Beijing,
China, JPT (J) Japanese in Tokyo, Japan, NI Norfolk Islanders, YRI
(Y) Yoruba in Ibadan, Nigeria
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gene may influence migraine susceptibility. Additional
analyses are required to determine if variants in KCNN3 are
associated with migraine risk. However, it is difficult to
conduct follow-up studies of the Norfolk pedigree because
of the uniqueness of our cohort, which includes character-
istics such as founder effect, geographical and cultural
isolation, high levels of consanguineous unions during early
population expansion, population bottlenecks, admixture
and homogeneous environment. Such unique population
qualities can prohibit follow-up studies [43].
The Nyholt et al. [42] study screened 155 ion transport
genes [42]. Variants within 12 of these genes displayed
nominal associations. Evidence for epistatic interaction
between potassium and calcium channel genes, KCNB2
and CACNB2, was also detected. Based on the findings of
this study, nominal associations found within KCNN3 may
be further explored by screening ion channel genes, par-
ticularly potassium channels, and/or genes involved in
oestrogen and dopamine metabolism and assessing poten-
tial gene–gene interactions.
Recently, a frameshift mutation in the potassium ion
channel gene, KCNK18, was found to segregate with auto-
somal dominant MA in a multigenerational pedigree [44].
High expression levels of KCNK18 were detected in the
trigeminal ganglion, which has long been implicated as the
initiation point for neural, vascular and inflammatory events
that underlie typical migraine symptoms. Although disrup-
tion of ion channels and transporters are known to cause
FHM, the Lafreniere study is the first to confirm ion channel
disruption in a common migraine subtype, MA. Although
the phenotype was a highly penetrant, autosomal dominant
form of MA, results provide compelling evidence that vari-
ants in other ion channel genes, in particular, potassium
channels such as KCNN3, may influence more common,
complex forms of migraine. Findings in the Norfolk pedigree
are consistent with the proposed connection between ion
channel disruption and this complex disorder.
Conclusion
This study provides evidence for association of multiple
variants in the KCNN3 ion channel gene with migraine
susceptibility in a large multigenerational pedigree from
the unique Norfolk Island genetic isolate. This the first
comprehensive analysis of this potential candidate gene in
migraine and also the first study that has utilised the unique
Norfolk Island large pedigree isolate to implicate a specific
migraine gene. Studies of additional variants in KCNN3 in
the Norfolk pedigree are now warranted, including the
previously studied polyglutamine tracts to determine if
these CAG repeats also show association with migraine in
the Norfolk isolate.
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